M&A Wrap: Q3 Rebound, Bristol-Myers, Monroe Capital, Avante Capital, MyoKardia, Alibaba, Greenbriar, Uber, Thoma Bravo

Bristol Myers buys heart drug developer. Lending executives including Monroe’s Theodore Koenig and Avante’s Jeri Harman talk about M&A bouncing back. Greenbriar invests in Uber’s logistics arm.